干酪乳酸杆菌代谢物对白假丝酵母菌生物被膜的体外抑菌效果及分子机制
Antifungal effects and relevant mechanisms of metabolites of Lactobacillus casei against Candida albicans biofilms in vitro

DOI: 10.6040/j.issn.1671-7554.0.2015.373

Keywords: 抑菌作用,干酪乳酸杆菌代谢物,生物被膜,双向电泳,白假丝酵母菌,
Candida albicans,Metabolite of Lactobacillus casei,Antifungal effects,Biofilm,Two-dimensional gel electrophoresis

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Flemming HC, Wingender J. The biofilm matrix[J]. Nat Rev Microbiol, 2010, 8(9): 623-633.
[2]	Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms[J]. Clin Microbiol Rev, 2002, 15(2): 167-193.
[3]	da Silva WJ, Seneviratne J, Parahitiyawa N, et al. Improvement of XTT assay performance for studies involving <i>Candida albicans </i>biofilms[J]. Braz Dent J, 2008, 19(4): 364-369.
[4]	Montagnoli C, Sandini S, Bacci A, et al. Immunogenicity and protective effect of recombinant enolase of <i>Candida albicans</i> in a murine model of systemic candidiasis[J]. Med. Mycol, 2004, 42(4): 319-324.
[5]	Bustamante CI. Treatment of <i>Candida</i> infection: a view from the trenches![J]. Curr Opin Infect Dis, 2005, 18(6): 490-495.
[6]	De Vuyst L, Schrijvers V, Paramithiotis S, et al. The biodiversity of lactic acid bacteria Greek traditional wheat sourdoughs is reflected in both composition and metabolite formation[J]. Appl Environ Microbiol, 2002, 68(12): 6059-6069.
[7]	魏利杰,徐摇琳,王锦卓,等.乳酸杆菌代谢产物对阴道常见致病菌抑制作用的试验研究 [J]. 吉林医学, 2013, 34(13): 2475-2476.
[8]	Jin Y, Samaranayake LP, Samaranayake Y, et al. Biofilm formation of <i>Candida albicans</i> is variably affected by saliva and dietary sugars[J]. Arch Oral Biol, 2004, 49(10): 789-798.
[9]	Vediyappan G, Rossignol T, dEnfert C. Interaction of <i>Candida albicans</i> biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans[J]. Antimicrob Agents Chemother, 2010, 54(5): 2096-2111.
[10]	Shibasaki S, Aoki W, Nomura T, et al. Evaluation of Mdh1 protein as an antigenic candidate for a vaccine against candidiasis[J]. Biocontrol Sci, 2014, 19(1): 51-55.
[11]	张立,蔡钢强.白色念珠菌的生物被膜[J]. 国际检验医学杂志, 2006, 27(12): 1112-1113.
[12]	Saville SP, Lazzell AL, Monteagudo C, et al. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of <i>Candida albicans</i> during infection[J]. Eukaryot Cell, 2003, 2(5): 1053-1060.
[13]	Ferreira AV, Prado CG, Carvalho RR, et al. <i>Candida albicans</i> and <i>Non-C. albicans Candida </i>Species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections[J]. Mycopathologia, 2013, 175(3-4): 265-272.
[14]	Nett JE, Sanchez H, Cain MT, et al. Interface of <i>Candida albicans</i> biofilm matrix-associated drug resistance and cell wall integrity regulation[J]. Eukaryot Cell, 2011, 10(12): 1660-1669.
[15]	Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections[J]. Lancet Infect Dis, 2011, 11(2): 142-151.
[16]	Ramage G, Vandewalle K, Wickes BL, et al. Characteristics of biofilm formation by <i>Candida albicans</i>[J]. Rev Iberoam Micol, 2001, 18(4): 163-170.
[17]	Tournu H, Serneels J, Van Dijck P. Fungal pathogens research: novel and improved molecular approaches for the discovery of antifungal drug targets[J]. Curr Drug Targets, 2005, 6(8): 909-922.
[18]	Ciofu O, Tolker-Nielsen T, Jensen P？, et al. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients[J]. Adv Drug Deliv Rev, 2015, 85: 7-23.
[19]	Lorenz MC, Bender JA, Fink GR. Transcriptional response of <i>Candida albicans</i> upon internalization by macrophages[J]. Eukaryot Cell, 2004, 3(5): 1076-1087.
[20]	Schwartz DS, Larsh HW. Comparative activities of glycolytic enzymes in yeast and mycelial forms of <i>Candida albicans</i>[J]. Mycopathologia, 1982, 78(2): 93-98.
[21]	Lu Y, Su C, Unoje O, et al. Quorum sensing controls hyphal initiation in <i>Candida albicans</i> through Ubr1-mediated protein degradation[J]. PNAS, 2014, 111(5): 1975-1980.
[22]	Mayer FL, Wilson D, Hube B. <i>Candida albicans</i> pathogenicity mechanisms[J]. Virulence, 2013, 4(2): 119-128.
[23]	Wayne PA. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard[M]. 3rd ed. Boston: Science Open Inc, 2008.
[24]	Ramage G, Martinez JP, Lopez-Ribot JL. <i>Candida</i> biofilms on implanted biomaterials: a clinically significant problem[J]. FEMS Yeast Res, 2006, 6(7): 979-986.
[25]	Azie N, Neofytos D, Pfaller M, et al. The PATH(Prospective Antifungal Therapy)Alliance registry and invasive fungal infections: update 2012[J]. Diagn Microbiol Infect Dis, 2012, 73(4): 293-300.

Full-Text